Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
Completed · Phase 1
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as irinotecan and capecitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may help capecitabine kill more tumor cells by making tumor cells more sensitive to the drug. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan and capecitabine in treating women with advanced breast cancer.
Key facts
- Study ID
- NCT00083148
- Run by
- Roswell Park Cancer Institute
- People needed
- 12
- Starts
- 2002-11-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2011-03-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.